# Retension Pharmaceuticals, Inc.: Executive or director change (Form 8-K, 2026-10-23)

**Trigger Strength Score:** 40/100

| Field | Value |
|---|---|
| Company | Retension Pharmaceuticals, Inc. |
| Ticker | RTSN |
| CIK | 2002988 |
| Filed | 2026-10-23 |
| Event date | 2026-10-21 |
| Primary trigger | Executive or director change |
| All items | 5.02 Executive or director change |
| Location | Mclean, VA |
| SIC code | 2834 |
| Accession | 0001213900-26-111794 |

## Why this score
- Primary trigger: Executive or director change.

Source: SEC EDGAR Form 8-K current reports (https://www.sec.gov/Archives/edgar/data/2002988/000121390026111794/ea0309450-8k_retension.htm). Last refreshed: 2026-11-04T21:30:57.707Z.
Event classification uses the item numbers companies report on Form 8-K; read the filing itself before acting. Informational only; not investment advice and not an offer or solicitation to buy or sell any security.